A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)
Clinical trial NCT03104400 · COMPLETED
Trial details
- NCT number
- NCT03104400
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-27
- Primary completion
- 2019-09-26
- Enrollment
- 1705
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.